Expression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the Breast

被引:8
作者
Yasui, Haruna [1 ,4 ]
Kawata, Takuya [1 ]
Muramatsu, Koji [1 ]
Kakuda, Yuko [1 ]
Oishi, Takuma [1 ]
Norose, Tomoko [1 ]
Notsu, Akifumi [3 ]
Nishimura, Seiichiro [2 ]
Fukuoka, Junya [4 ]
Sugino, Takashi [1 ]
机构
[1] Shizuoka Canc Ctr, Div Pathol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan
[2] Clin Res Ctr, Div Breast Surg, Nagasaki, Japan
[3] Clin Res Ctr, Dept Biostat, Nagasaki, Japan
[4] Nagasaki Univ, Dept Pathol, Grad Sch Biomed Sci, Nagasaki, Japan
基金
日本学术振兴会;
关键词
breast cancer; invasive lobular carcinoma; E-cadherin; N-terminal; C-terminal; CANCER; CLEAVAGE; CDH1; IMMUNOHISTOCHEMISTRY; CORRELATE; CATENIN; IMPACT;
D O I
10.1097/PAS.0000000000001822
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Invasive lobular carcinoma (ILC) of the breast is characterized by the discohesive growth of tumor cells, which is mainly associated with the complete loss of E-cadherin (E-cad) expression. However, some aberrant expression patterns of E-cad protein that are inconsistent with their morphologies have been reported in ILC. We report herein ILC cases expressing a new type of abnormal E-cad protein that lacks the N-terminal domain, but conserves the C-terminal domain on the cell membrane. Immunohistochemical staining of 299 ILC cases using specific antibodies against the N-terminal or C-terminal region of E-cad revealed that 227 (76%) cases showed loss of the membranous expression of both terminuses (N-/C-) and 72 (24%) cases showed expression of only the C-terminus (N-/C+). In all cases, the expression of p120-catenin and beta-catenin coincided with the expression of the C-terminus of E-cad. Clinicopathologic analysis revealed that N-/C+ expression in ILC cells was significantly associated with the histologic subtype (especially mixed-type ILC with another histologic type) and immunohistochemical molecular subtype (especially the triple-negative subtype), but not with prognostic factors (pT or pN). In addition, 12 of 15 cases (80%) with aberrant cytoplasmic localization of the N-terminal of E-cad showed diffuse membranous expression of the C-terminal domain. Additional immunohistochemistry using an antibody recognizing the extracellular juxtamembrane region showed that 28 (39%) of the N-/C+ cases had lost membranous expression, suggesting diversity in the deletion pattern of the N-terminal region. Our findings provide a novel mechanism for the loss of E-cad function because of N-terminal-deficient E-cad protein in ILC.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
[21]   Expression of E-cadherin, α-catenin, and β-catenin in tubulolobular carcinoma of the breast [J].
Kuroda, H ;
Tamaru, J ;
Takeuchi, I ;
Ohnisi, K ;
Sakamoto, G ;
Adachi, A ;
Kaneko, K ;
Itoyama, S .
VIRCHOWS ARCHIV, 2006, 448 (04) :500-505
[22]   Expression of E-cadherin, α-catenin, and β-catenin in tubulolobular carcinoma of the breast [J].
Hajime Kuroda ;
Jun-ichi Tamaru ;
Ikuya Takeuchi ;
Kiyoshi Ohnisi ;
Goi Sakamoto ;
Akiko Adachi ;
Kou Kaneko ;
Shinji Itoyama .
Virchows Archiv, 2006, 448 :500-505
[23]   Insights into E-Cadherin Impairment in CDH1-Unaltered Invasive Lobular Carcinoma: A Comprehensive Bioinformatic Study [J].
Uchida, Shiro ;
Sugino, Takashi .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
[24]   Histiocytoid breast carcinoma: Solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant [J].
Fujiwara, M ;
Horiguchi, M ;
Mori, S ;
Yokoyama, K ;
Horiguchi, H ;
Fukazawa, M ;
Fujiwara, H ;
Yano, Y ;
Satoh, H ;
Kamma, H .
PATHOLOGY INTERNATIONAL, 2005, 55 (06) :353-359
[25]   E-cadherin complex protein expression and survival in ovarian carcinoma [J].
Davidson, B ;
Gotlieb, WH ;
Ben-Baruch, G ;
Nesland, JM ;
Bryne, M ;
Goldberg, I ;
Kopolovic, J ;
Berner, A .
GYNECOLOGIC ONCOLOGY, 2000, 79 (03) :362-371
[26]   Clinical significance of Twist, E-cadherin, and N-cadherin protein expression in endometrioid adenocarcinoma [J].
Xie, Xinping ;
Zheng, Xiu ;
Wang, Jinhua ;
Chen, Lihong .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (05) :817-822
[27]   Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast [J].
Goldstein, NS ;
Kestin, LL ;
Vicini, FA .
CANCER, 2001, 92 (04) :738-747
[28]   E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis [J].
Vos, CBJ ;
CletonJansen, AM ;
Berx, G ;
deLeeuw, WJF ;
terHaar, NT ;
vanRoy, F ;
Cornelisse, CJ ;
Peterse, JL ;
vandeVijver, MJ .
BRITISH JOURNAL OF CANCER, 1997, 76 (09) :1131-1133
[29]   Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma [J].
Lehr, HA ;
Folpe, A ;
Yaziji, H ;
Kommoss, F ;
Gown, AM .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (02) :190-196
[30]   Germline Mutations of the E-Cadherin Gene in Families With Inherited Invasive Lobular Breast Carcinoma But No Diffuse Gastric Cancer [J].
Xie, Ze Ming ;
Li, Lai Sheng ;
Laquet, Claire ;
Penault-Llorca, Frederique ;
Uhrhammer, Nancy ;
Xie, Xiao Ming ;
Bignon, Yves Jean .
CANCER, 2011, 117 (14) :3112-3117